High‑Dose Amoxicillin Therapy for Acute Otitis Media in Children < 2 years
Dosage and Administration
- Prescribe high‑dose amoxicillin at 80–90 mg/kg/day divided into two doses for a 10‑day course in children younger than 2 years. (American Academy of Pediatrics) 1 – Evidence level not specified
- Calculate the total daily dose by multiplying the child’s weight (kg) by 80–90 mg/kg, then split the result into two equal doses given 12 hours apart. (American Academy of Pediatrics) 1 – Evidence level not specified
Indications for Amoxicillin‑Clavulanate
- Switch to high‑dose amoxicillin‑clavulanate (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate, divided BID) when the child has received amoxicillin within the prior 30 days. (American Academy of Pediatrics) 1 – Evidence level not specified
- Switch to high‑dose amoxicillin‑clavulanate when concurrent purulent conjunctivitis is present. (American Academy of Pediatrics) 1 – Evidence level not specified
Management of Inadequate Clinical Response
- If no clinical improvement is observed within 48–72 hours, first reassess the diagnosis of acute otitis media. (American Academy of Pediatrics) 1 – Evidence level not specified
- If the initial regimen was amoxicillin alone, change to high‑dose amoxicillin‑clavulanate. (American Academy of Pediatrics) 1 – Evidence level not specified
- If the child fails to improve on amoxicillin‑clavulanate, consider ceftriaxone 50 mg/kg administered intramuscularly or intravenously for three days. (American Academy of Pediatrics) 1 – Evidence level not specified
Risk‑Based First‑Line Choice
- Use amoxicillin‑clavulanate as first‑line therapy in children with recent antibiotic exposure or who attend daycare, because β‑lactamase‑producing Haemophilus influenzae is a common cause of treatment failure. (American Academy of Pediatrics) 1 – Evidence level not specified
Amoxicillin Dosing for Otitis Media in Infants
First-Line Treatment Recommendation
- The American Academy of Pediatrics recommends high-dose amoxicillin at 80-90 mg/kg/day given in 2 divided doses as the standard first-line therapy for acute otitis media in infants and children, including those as young as 11 weeks old 2, 3
- High-dose amoxicillin provides adequate middle ear fluid concentrations to cover Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 2, 3
Rationale for High-Dose Therapy
- High-dose amoxicillin achieves middle ear fluid levels that exceed the minimum inhibitory concentration for intermediately resistant S. pneumoniae for a longer duration of the dosing interval 3
- Approximately 87% of S. pneumoniae isolates are susceptible to high-dose amoxicillin, compared to only 83% for standard-dose therapy 3
When to Consider Amoxicillin-Clavulanate Instead
- Switch to high-dose amoxicillin-clavulanate if the infant received amoxicillin in the previous 30 days, or if concurrent purulent conjunctivitis is present, or if coverage for β-lactamase-producing H. influenzae or M. catarrhalis is specifically desired 2
Treatment Duration and Monitoring
- Treat for 10 days in children under 2 years of age 2
- Clinical improvement should be evident within 48-72 hours; if no improvement occurs, reassess the diagnosis and consider treatment failure 4
- If treatment fails after 48-72 hours on amoxicillin, switch to amoxicillin-clavulanate or consider ceftriaxone 2, 3
Important Clinical Caveats
- The 14:1 ratio formulation of amoxicillin to clavulanate is preferred when using combination therapy, as it causes less diarrhea than other ratios 2, 3
- Pain management should be addressed regardless of antibiotic choice 4
High‑Dose Amoxicillin Therapy for Acute Otitis Media in Children
Recommended Dosing and Duration
- The American Academy of Pediatrics (AAP) recommends prescribing high‑dose amoxicillin at 80–90 mg/kg/day, divided twice daily, for 10 days in children younger than 6 years with acute otitis media (e.g., a 5‑year‑old weighing 23 kg would receive 1,840–2,070 mg total daily, split into two doses). [5][6]
Pharmacodynamic Rationale
- High‑dose amoxicillin achieves middle‑ear fluid concentrations that exceed the minimum inhibitory concentration for ≈ 87 % of Streptococcus pneumoniae isolates (including intermediately resistant strains with penicillin MIC 0.12–1.0 µg/mL), compared with only 83 % coverage using standard dosing. This superior exposure underlies the recommended high‑dose regimen. 5
- The regimen provides adequate antimicrobial coverage against the three principal pathogens of acute otitis media—Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 5
Indications for Switching to Amoxicillin‑Clavulanate
- The AAP advises switching to high‑dose amoxicillin‑clavulanate (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate in a 14:1 ratio, divided BID) when any of the following are present:
- The child has received amoxicillin within the preceding 30 days. 5
Advantages of the 14:1 Ratio Amoxicillin‑Clavulanate Formulation
- The 14:1 amoxicillin‑clavulanate formulation (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate) is associated with significantly less diarrhea than older 7:1 formulations, while preserving efficacy against β‑lactamase‑producing organisms. 5
Comparative Efficacy
- High‑dose amoxicillin‑clavulanate achieves 96 % eradication of S. pneumoniae from middle‑ear fluid by days 4–6 of therapy, a result that is significantly superior to azithromycin. 5